Issued Patents All Time
Showing 26–45 of 45 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8497254 | Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators | Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-07-30 |
| 8492561 | Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators | Santosh C. Sinha, Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-07-23 |
| 8492410 | Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators | Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-07-23 |
| 8486918 | Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor | Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-07-16 |
| 8404663 | Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators | Santosh C. Sinha, Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-03-26 |
| 8399492 | Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators | Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2013-03-19 |
| 8362022 | Selective subtype alpha 2 adrenergic agents and methods for use thereof | Todd M. Heidelbaugh, Ken Chow, Santosh C. Sinha, Phong X. Nguyen, Ling Li +2 more | 2013-01-29 |
| 8329918 | Selective alpha 2B/2C agonists | Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Santosh C. Sinha +2 more | 2012-12-11 |
| 8288555 | Alkene derivatives as sphingosine 1-phosphate (S1P) receptor modulators | Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im | 2012-10-16 |
| 8183414 | N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors | Ken Chow, Janet A. Takeuchi, Ling Li, Todd M. Heidelbaugh, Phong X. Nguyen +3 more | 2012-05-22 |
| 8071636 | Methods of treating alpha adrenergic mediated conditions | Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Michael E. Garst +3 more | 2011-12-06 |
| 8063231 | Methods of treating alpha adrenergic mediated conditions | Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Michael E. Garst +1 more | 2011-11-22 |
| 7884244 | Therapeutic fluoroethylcyano guanidines | Ken Chow, Evelyn G. Corpuz, Daniel W. Gil, Michael E. Garst | 2011-02-08 |
| 7754768 | Methods and compositions for modulating alpha adrenergic receptor activity | Ken Chow, Daniel W. Gil, Michael E. Garst, Larry A. Wheeler | 2010-07-13 |
| 7709507 | Therapeutic fluoroethyl ureas | Ken Chow, Evelyn G. Corpuz, Daniel W. Gil, Michael E. Garst | 2010-05-04 |
| 7598417 | Substituted fluoroethyl ureas as alpha 2 adrenergic agents | Ken Chow, Evelyn G. Corpuz, Daniel W. Gil, Michael E. Garst | 2009-10-06 |
| 7335803 | Methods and compositions for modulating alpha adrenergic receptor activity | Ken Chow, Daniel W. Gil, Michael E. Garst, Larry A. Wheeler | 2008-02-26 |
| 6545182 | Methods and compositions for modulating alpha adrenergic receptor activity | Ken Chow, Daniel W. Gil, Michael E. Garst, Wheeler A. Larry | 2003-04-08 |
| 6534542 | (2-hydroxy)ethyl-thioureas useful as modulators of &agr;2B adrenergic receptors | Ken Chow, Daniel W. Gil, Michael E. Garst | 2003-03-18 |
| 6313172 | Methods and compositions for modulating alpha adrenergic receptor activity | Ken Chow, Daniel W. Gil, Michael E. Garst, Larry A. Wheeler | 2001-11-06 |